RT @DrGattiMays@twitter.com

Phase 1 trial by @aszim13@twitter.com that TDM-1 + temozolamide may reduce risk of new brain metastases in patients with metastatic HER2+ with known CNS metastases #bcsm #Brainmets #HER2 👏👏 https://twitter.com/filippomontemu1/status/1619602480073150465

🐦🔗: https://twitter.com/DrGattiMays/status/1619680319082463232